Headlands Technologies LLC Makes New $53,000 Investment in Omnicell, Inc. (NASDAQ:OMCL)

Headlands Technologies LLC acquired a new stake in shares of Omnicell, Inc. (NASDAQ:OMCL) in the 4th quarter, HoldingsChannel reports. The fund acquired 1,186 shares of the company’s stock, valued at approximately $53,000.

A number of other institutional investors also recently modified their holdings of the company. Smartleaf Asset Management LLC increased its holdings in Omnicell by 51.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 803 shares of the company’s stock valued at $35,000 after purchasing an additional 273 shares during the period. Van ECK Associates Corp increased its stake in shares of Omnicell by 47.0% during the fourth quarter. Van ECK Associates Corp now owns 985 shares of the company’s stock valued at $44,000 after buying an additional 315 shares during the period. First Horizon Advisors Inc. raised its holdings in shares of Omnicell by 36.3% during the fourth quarter. First Horizon Advisors Inc. now owns 1,333 shares of the company’s stock valued at $59,000 after acquiring an additional 355 shares in the last quarter. KBC Group NV lifted its stake in Omnicell by 60.8% in the fourth quarter. KBC Group NV now owns 2,057 shares of the company’s stock worth $92,000 after acquiring an additional 778 shares during the period. Finally, AlphaQuest LLC boosted its holdings in Omnicell by 307.8% in the fourth quarter. AlphaQuest LLC now owns 3,576 shares of the company’s stock valued at $159,000 after acquiring an additional 2,699 shares in the last quarter. 97.70% of the stock is currently owned by hedge funds and other institutional investors.

Omnicell Stock Down 3.3 %

OMCL stock opened at $31.60 on Tuesday. The business has a 50 day moving average of $37.91 and a 200 day moving average of $42.16. The firm has a market cap of $1.48 billion, a PE ratio of 117.04, a price-to-earnings-growth ratio of 7.53 and a beta of 0.78. Omnicell, Inc. has a twelve month low of $25.12 and a twelve month high of $55.75. The company has a quick ratio of 1.22, a current ratio of 1.37 and a debt-to-equity ratio of 0.13.

Omnicell (NASDAQ:OMCL) last issued its quarterly earnings results on Thursday, February 6th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.12). Omnicell had a net margin of 1.13% and a return on equity of 3.82%. On average, research analysts forecast that Omnicell, Inc. will post 1.09 EPS for the current fiscal year.

Analyst Ratings Changes

OMCL has been the subject of several research reports. Bank of America decreased their price objective on shares of Omnicell from $54.00 to $46.00 and set a “neutral” rating for the company in a report on Monday, January 6th. JPMorgan Chase & Co. cut their price objective on Omnicell from $44.00 to $36.00 and set a “neutral” rating on the stock in a research report on Thursday, March 20th. Wells Fargo & Company decreased their target price on Omnicell from $49.00 to $40.00 and set an “equal weight” rating for the company in a research report on Monday, January 13th. StockNews.com lowered Omnicell from a “buy” rating to a “hold” rating in a research report on Monday, March 24th. Finally, Benchmark reiterated a “buy” rating and issued a $62.00 price objective on shares of Omnicell in a report on Tuesday, February 4th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $51.00.

Omnicell Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.